ArticleJournal of clinical medicine2023

Efficacy and Safety of 6-Weekly versus 12-Weekly Intravenous Methylprednisolone in Moderate-to-Severe Active Thyroid-Associated Ophthalmopathy.

Kenneth K H Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.